Publication | Open Access

Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs)

Biomarker (Medicine)Prognostic BiomarkersSomatic VariantCheckpoint InhibitorsMedicineBiomarker TargetImmunologyTumor ImmunityPathologyImmune SurveillancePredictive BiomarkersImmune Checkpoint InhibitorMolecular DiagnosticsImmunotherapyOncologyCancer ResearchSomatic Alterations